Neha Korde
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Oncology top 2%
- CAR-T cell therapy research
- Peptidase Inhibition and Analysis
Papers in
- Hematology 145
- Multiple Myeloma Research and Treatments 142
- Genetics 33
- Chronic Lymphocytic Leukemia Research 17
- Myeloproliferative Neoplasms: Diagnosis and Treatment 12
- Co-authors
- Ola Landgren (85 shared papers)Sham Mailankody (52 shared papers)Sigurdur Yngvi Kristinsson (11 shared papers)Ingemar Turesson (4 shared papers)Mark J. Roschewski (18 shared papers)Alexander M. Lesokhin (30 shared papers)Hani Hassoun (30 shared papers)Dickran Gano Kazandjian (12 shared papers)
- Journals
- Blood (48 papers)Blood Advances (9 papers)Blood Cancer Journal (9 papers)Transplantation and Cellular Therapy (8 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesSwedenIceland
In The Last Decade
Neha Korde
169 papers receiving 4.3k citations
Neha Korde's Hit Papers
Peers
Comparison fields: 5 of 117
- Hematology 2.8k
- Oncology 1.6k
- Genetics 492
- Molecular Biology 1.9k
- Immunology 538
Countries citing papers authored by Neha Korde
This map shows the geographic impact of Neha Korde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neha Korde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neha Korde more than expected).
Fields of papers citing papers by Neha Korde
This network shows the impact of papers produced by Neha Korde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neha Korde. The network helps show where Neha Korde may publish in the future.
Co-authors
The 25 scholars most cited alongside Neha Korde, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 175 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | GPRC5D-Targeted CAR T Cells for Myeloma Hit paper breakdown → | 2022 | 326 |
| 2 | 2015 | 264 | |
| 3 | 2011 | 161 | |
| 4 | 2011 | 156 | |
| 5 | 2014 | 148 | |
| 6 | 2016 | 144 | |
| 7 | 2014 | 113 | |
| 8 | 2012 | 105 | |
| 9 | 2001 | 100 | |
| 10 | 2007 | 100 | |
| 11 | 2015 | 98 | |
| 12 | 2015 | 94 | |
| 13 | 2017 | 89 | |
| 14 | 2021 | 89 | |
| 15 | 2013 | 83 | |
| 16 | 2015 | 79 | |
| 17 | 2021 | 76 | |
| 18 | 2013 | 70 | |
| 19 | 2019 | 69 | |
| 20 | 2022 | 64 |
About Neha Korde
Neha Korde is a scholar working on Hematology, Genetics, Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 175 papers that have together received 4.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (142 papers), Protein Degradation and Inhibitors (47 papers), Peptidase Inhibition and Analysis (21 papers), Chronic Lymphocytic Leukemia Research (17 papers), Cancer Treatment and Pharmacology (14 papers), CAR-T cell therapy research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (12 papers) and Monoclonal and Polyclonal Antibodies Research (12 papers). The work is most often cited by research in Hematology (2.8k citations), Oncology (1.6k citations), Genetics (492 citations), Molecular Biology (1.9k citations) and Immunology (538 citations). Neha Korde has collaborated with scholars based in United States, Sweden and Iceland. Frequent co-authors include Ola Landgren, Sham Mailankody, Sigurdur Yngvi Kristinsson, Ingemar Turesson, Mark J. Roschewski, Alexander M. Lesokhin, Hani Hassoun, Dickran Gano Kazandjian, Mary Kwok and Rene Costello. Their work appears in journals such as Blood, Blood Advances, Blood Cancer Journal, Transplantation and Cellular Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.